Compounds > bicalutamide

bicalutamide and Hot Flashes

bicalutamide has been researched along with Hot Flashes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deville, C; Loprinzi, CL; Smith, TJ1
Bhattacharya, S; Chowdhury, S; Hasabou, N; Heidenreich, A; Klotz, L; Shore, ND; Siemens, DR; van Os, S; Villers, A; Wang, F1
Hakariya, H; Hara, T; Hayashi, M; Igawa, T; Iwasaki, S; Kanetake, H; Kusaba, Y; Sakai, H; Tsurusaki, T; Yura, M1
Gehrman, PR; Hanisch, LJ1
Andersen, JT; Lodding, P; Nyman, CR; Sandin, T; Varenhorst, E1
Engstrom, C1

Trials

2 trial(s) available for bicalutamide and Hot Flashes

ArticleYear
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.
    The Lancet. Oncology, 2016, Volume: 17, Issue:2

    Topics: Aged; Aged, 80 and over; Anemia; Anilides; Arthralgia; Back Pain; Benzamides; Constipation; Disease Progression; Disease-Free Survival; Double-Blind Method; Dyspnea; Fatigue; Fractures, Spontaneous; Heart Failure; Hot Flashes; Humans; Hydronephrosis; Hypertension; Male; Middle Aged; Myocardial Infarction; Nausea; Nitriles; Patient Dropouts; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Tosyl Compounds

2016
Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
    Urology, 2009, Volume: 73, Issue:3

    Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Leuprolide; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Quality of Life; Steroids; Tosyl Compounds

2009

Other Studies

4 other study(ies) available for bicalutamide and Hot Flashes

ArticleYear
Oxybutynin for Hot Flashes Due to Androgen Deprivation in Men.
    The New England journal of medicine, 2018, 05-03, Volume: 378, Issue:18

    Topics: Aged; Androgen Antagonists; Anilides; Hot Flashes; Humans; Leuprolide; Male; Mandelic Acids; Muscarinic Antagonists; Nitriles; Prostatic Neoplasms; Tosyl Compounds

2018
Circadian rhythm of hot flashes and activity levels among prostate cancer patients on androgen deprivation therapy.
    The aging male : the official journal of the International Society for the Study of the Aging Male, 2011, Volume: 14, Issue:4

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Circadian Rhythm; Hot Flashes; Humans; Leuprolide; Male; Middle Aged; Motor Activity; Nitriles; Prostatic Neoplasms; Tosyl Compounds

2011
The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy.
    BJU international, 2005, Volume: 96, Issue:7

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Attitude; Follow-Up Studies; Hot Flashes; Humans; Male; Middle Aged; Neoplasm Staging; Nitriles; Orchiectomy; Patient Satisfaction; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds

2005
Hot flashes.
    Clinical journal of oncology nursing, 2006, Volume: 10, Issue:4

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Arrhythmias, Cardiac; Evidence-Based Medicine; Hot Flashes; Humans; Male; Nitriles; Nursing Assessment; Patient Care Planning; Prostatic Neoplasms; Sweating; Tosyl Compounds

2006